Embedded Files
HIVE takes pride in its ability to identify key strategic levers for clients in pre-launch rollout, customer engagement, dossier creation, and resource allocation. We are not a 'checklist' company. We continually gauge and reassess the progress of each tactic throughout the client's cross-functional & access journey.
HIVE takes pride in its ability to identify key strategic levers for clients in pre-launch rollout, customer engagement, dossier creation, and resource allocation. We are not a 'checklist' company. We continually gauge and reassess the progress of each tactic throughout the client's cross-functional & access journey.
1. Canadian Launches (Concierge Service)
1. Canadian Launches (Concierge Service)
1. Comprehensive HTA Strategy - No submission is the same; we will shape your value narrative with concise and straightforward messaging, while aligning with patient and clinical community views.
1. Comprehensive HTA Strategy - No submission is the same; we will shape your value narrative with concise and straightforward messaging, while aligning with patient and clinical community views.
2. Pricing Strategy - Private, public and out-of-pocket are all critical segments for momentum and profitability.
2. Pricing Strategy - Private, public and out-of-pocket are all critical segments for momentum and profitability.
3. Payer Insights - Everything we do is consistent with evolving payer and decision-maker trends.
3. Payer Insights - Everything we do is consistent with evolving payer and decision-maker trends.
4. Advocacy - Helping clients identify and strengthen relationships with key community partners.
4. Advocacy - Helping clients identify and strengthen relationships with key community partners.
5. Patient Support Programs - Evaluating the need and impact of such programs to help set clear and realistic expectations.
5. Patient Support Programs - Evaluating the need and impact of such programs to help set clear and realistic expectations.
2. Global Access Strategy
2. Global Access Strategy
1. Pipeline Optimization from HTA lens (shaping protocols when transitioning from Ph2 to Ph3)
1. Pipeline Optimization from HTA lens (shaping protocols when transitioning from Ph2 to Ph3)
2. Launching sequencing and mitigation strategies
2. Launching sequencing and mitigation strategies
3. Mid-term vs long-term scenario planning
3. Mid-term vs long-term scenario planning
4. Expansion from US / EU to other markets
4. Expansion from US / EU to other markets
3. U.S. Market Access Strategy
3. U.S. Market Access Strategy
1. Pre-Launch Access Planning: Solidifying your narrative for ACMP submissions.
1. Pre-Launch Access Planning: Solidifying your narrative for ACMP submissions.
2. Payer Engagement & Value Communication: Ensuring access decisions are well informed using your clinical and economic data.
2. Payer Engagement & Value Communication: Ensuring access decisions are well informed using your clinical and economic data.
3. Contracting & Formulary negotiations: Formulary access is not given, it is negotiated (we help you structure the engagement for the optimal outcome).
3. Contracting & Formulary negotiations: Formulary access is not given, it is negotiated (we help you structure the engagement for the optimal outcome).
4. Policy Readiness (MFN, IRA): We help you proactively model exposure risks and design mitigation plans throughout your product life cycle.
4. Policy Readiness (MFN, IRA): We help you proactively model exposure risks and design mitigation plans throughout your product life cycle.
4. Digital Health Strategy
4. Digital Health Strategy
1. For developers and biopharma, whether it is a value add-on to boost market differentiation or a standalone product, we will help you assess and establish the best path forward for a commercial opportunity.
1. For developers and biopharma, whether it is a value add-on to boost market differentiation or a standalone product, we will help you assess and establish the best path forward for a commercial opportunity.
2. We help shape the global launch strategy for optimal ROI, integrating Evidence Generation into the rollout process.
2. We help shape the global launch strategy for optimal ROI, integrating Evidence Generation into the rollout process.
3. Identifying the best market penetration opportunities involves analyzing different payer profiles and payment models specific to each region, helping you determine where to invest and how long it will take to reach your goals.
3. Identifying the best market penetration opportunities involves analyzing different payer profiles and payment models specific to each region, helping you determine where to invest and how long it will take to reach your goals.
Page updated
Google Sites
Report abuse